Salomon / ACS / Timms AE / Need AB / GE / Tricklebank / Proc Natl Acad Sci U S A / Google / Niculescu AB / Creative Commons / BioMed Central Ltd. / Geddes AE / /
Country
Australia / / /
Facility
Medical Research Institute / Arch Gen Psychiatry / NMDAR complex / University of Wollongong / Schizophrenia Research Institute / /
IndustryTerm
monoaminergic systems / treatment of depression / chemical class / chemical and functional diversity / mGluR5 pharmaceutical modulators / treatment of psychiatric disorders / therapeutic binding site / treatment of anxiety and Fragile X Syndrome / online submission / /
MedicalCondition
DF / major depressive disorder / JE / Glutamatergic dysfunction / both schizophrenia / X Syndrome / disorder / mood disorders / neuropsychiatric disorders / affective disorders / MS / inherently human disorders / brain pathology / schizophrenia / chronic treatment / cognitive impairment / fragile X syndrome / psychiatric disorders / diseases / depression / treatment-resistant depression / disorders / treatment-resistant major depression / /
NaturalFeature
Tsuang MT / /
Organization
University of Wollongong / Schizophrenia Research Institute / Tamalin / Faculty of Science / Medicine and Health / Centre for Translational Neuroscience / Illawarra Health and Medical Research Institute / United Nations / /
Person
Ian Scott / David Weaver / Jeffrey Conn / Arch Psychiatry / Scott Daniels / Ann N Y Acad Sci / /
An upper limit for macromolecular crowding effects